Skip to content
Disclosery

STEMPOINT CAPITAL LP

Follow

13F filer, CIK 1952142, NEW YORK, NY

STEMPOINT CAPITAL LP reported $311,575,076 across 53 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14. Its ten largest share positions make up 50.16% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-25-002033

Period
2025-06-30
Reported value
$312M
Holdings
53
Top 10 weight
50.16%
New
21
Sold out
29

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CDTXnew+266,774$13M
LEGNnew+270,144$9.59M
RYTMadded+142,936$9.03M
CNTAadded+672,337$8.83M
MLYSnew+631,586$8.55M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ROIVreduced-1,977,079-$22.3M
RVMDexited-318,782-$11.3M
NUVLreduced-130,573-$9.96M
XENEexited-274,633-$9.21M
CGONexited-289,823-$7.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001420506-25-002033, largest first. % of portfolio is the value over $310,594,951, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,731,191 shares; 2024Q4: 2,872,601 shares; 2025Q1: 1,598,594 shares; 2025Q2: 2,372,634 shares 2,372,634$22.2M7.15%+774,040Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 671,001 shares; 2024Q4: 1,118,508 shares; 2025Q1: 853,472 shares; 2025Q2: 1,300,860 shares 1,300,860$20.8M6.7%+447,388Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 166,307 shares; 2025Q1: 566,212 shares; 2025Q2: 528,115 shares 528,115$18.7M6.02%-38,097Timeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 83,662 shares; 2024Q4: 641,964 shares; 2025Q1: 593,335 shares; 2025Q2: 1,265,672 shares 1,265,672$16.6M5.35%+672,337Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 40,936 shares; 2025Q2: 52,694 shares 52,694$15.9M5.13%+11,758Timeline
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 421,222 shares; 2024Q4: 614,812 shares; 2025Q1: 346,756 shares; 2025Q2: 266,094 shares 266,094$14M4.51%-80,662
ACLXARCELLX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 60,076 shares; 2024Q4: not reported; 2025Q1: 273,774 shares; 2025Q2: 201,452 shares 201,452$13.3M4.27%-72,322Timeline
CDTXCIDARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 47,642 shares; 2025Q1: not reported; 2025Q2: 266,774 shares 266,774$13M4.18%newTimeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 41,268 shares; 2024Q4: 208,016 shares; 2025Q1: 33,816 shares; 2025Q2: 176,752 shares 176,752$11.2M3.6%+142,936Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 48,918 shares; 2024Q4: 416,968 shares; 2025Q1: 192,352 shares; 2025Q2: 351,124 shares 351,124$10M3.23%+158,772Timeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 282,050 shares; 2024Q4: 584,328 shares; 2025Q1: 667,078 shares; 2025Q2: 707,915 shares 707,915$9.9M3.19%+40,837Timeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 270,144 shares 270,144$9.59M3.09%newTimeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 960,307 shares; 2025Q2: 6,649,244 shares 6,649,244$9.38M3.02%+5,688,937Timeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 26,421 shares; 2025Q2: 250,438 shares 250,438$8.76M2.82%+224,017Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 400,101 shares; 2025Q1: not reported; 2025Q2: 631,586 shares 631,586$8.55M2.75%newTimeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 90,000 shares; 2025Q1: 731,039 shares; 2025Q2: 572,615 shares 572,615$7.98M2.57%-158,424Timeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,769,819 shares; 2024Q4: 2,712,778 shares; 2025Q1: 2,578,860 shares; 2025Q2: 601,781 shares 601,781$6.78M2.18%-1,977,079Timeline
AKROAKERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 156,185 shares; 2025Q2: 116,779 shares 116,779$6.23M2.01%-39,406Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 106,610 shares; 2025Q1: 87,059 shares; 2025Q2: 61,578 shares 61,578$6.2M2%-25,481Timeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 182,918 shares; 2024Q4: 350,573 shares; 2025Q1: 240,826 shares; 2025Q2: 686,539 shares 686,539$6.14M1.98%+445,713Timeline
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 300,000 shares; 2024Q4: 721,209 shares; 2025Q1: 89,833 shares; 2025Q2: 900,338 shares 900,338$5.85M1.88%+810,505Timeline
LENZLENZ THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 183,912 shares 183,912$5.39M1.74%newTimeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 145,234 shares; 2025Q1: 190,401 shares; 2025Q2: 59,828 shares 59,828$4.56M1.47%-130,573Timeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 992,803 shares; 2025Q1: 386,837 shares; 2025Q2: 386,790 shares 386,790$4.37M1.41%-47Timeline
VTGNVISTAGEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,846,792 shares; 2024Q4: 2,328,492 shares; 2025Q1: 2,366,554 shares; 2025Q2: 2,413,254 shares 2,413,254$4.12M1.33%+46,700Timeline
APGEAPOGEE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 84,466 shares 84,466$3.67M1.18%newTimeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 132,703 shares; 2024Q4: not reported; 2025Q1: 66,999 shares; 2025Q2: 165,885 shares 165,885$3.49M1.12%+98,886Timeline
TARAPROTARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 942,857 shares; 2024Q4: 332,394 shares; 2025Q1: 1,190,579 shares; 2025Q2: 1,143,677 shares 1,143,677$3.47M1.12%-46,902Timeline
HELIX ACQUISITION CORP IIHELIX ACQUISITION CORP IIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 200,000 shares; 2024Q4: 200,900 shares; 2025Q1: 200,900 shares; 2025Q2: 315,812 shares 315,812$3.29M1.06%+114,912
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 579,500 shares; 2025Q1: not reported; 2025Q2: 329,254 shares 329,254$3.1M1%newTimeline
ARQTARCUTIS BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,778,318 shares; 2024Q4: 500,966 shares; 2025Q1: 440,073 shares; 2025Q2: 205,672 shares 205,672$2.88M0.93%-234,401Timeline
RZLTREZOLUTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 644,654 shares 644,654$2.88M0.93%newTimeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,203,941 shares 1,203,941$2.78M0.9%newTimeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 104,585 shares; 2025Q2: 152,652 shares 152,652$2.76M0.89%+48,067Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 216,440 shares; 2024Q4: 186,413 shares; 2025Q1: 250,564 shares; 2025Q2: 174,754 shares 174,754$2.47M0.79%-75,810Timeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 4,672 shares 4,672$2.45M0.79%newTimeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 94,885 shares; 2024Q4: not reported; 2025Q1: 208,437 shares; 2025Q2: 54,630 shares 54,630$2.36M0.76%-153,807Timeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 49,415 shares; 2024Q4: 145,876 shares; 2025Q1: 342,062 shares; 2025Q2: 89,933 shares 89,933$2.08M0.67%-252,129Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 200,785 shares 200,785$2.04M0.66%newTimeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 50,000 shares; 2024Q4: not reported; 2025Q1: 96,615 shares; 2025Q2: 141,021 shares 141,021$1.61M0.52%+44,406Timeline
FRNMPERCEPTIVE CAP SOLUTIONS CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 150,000 shares; 2024Q4: 150,000 shares; 2025Q1: 150,000 shares; 2025Q2: 150,000 shares 150,000$1.59M0.51%0Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 174,034 shares; 2024Q4: 134,178 shares; 2025Q1: not reported; 2025Q2: 32,255 shares 32,255$1.36M0.44%newTimeline
GHRSGH RESEARCH PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 100,826 shares 100,826$1.23M0.4%newTimeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 208,800 shares 208,800$1.07M0.34%newTimeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 141,714 shares; 2025Q1: 49,241 shares; 2025Q2: 16,770 shares 16,770$927K0.3%-32,471Timeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 9,434 shares; 2025Q1: not reported; 2025Q2: 40,000 shares 40,000$795K0.26%newTimeline
ADCTADC THERAPEUTICS SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 283,286 shares 283,286$759K0.24%newTimeline
VERONA PHARMA PLCVERONA PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 28,136 shares; 2025Q1: not reported; 2025Q2: 7,407 shares 7,407$701K0.23%new
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 87,748 shares 87,748$671K0.22%newTimeline
MIND MEDICINE MINDMED INCMIND MEDICINE MINDMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 90,852 shares 90,852$590K0.19%new

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
ROIVROIVANT SCIENCES LTD SHScall915,000$618Knew
IMVTIMMUNOVANT INC COMcall100,000$310Knew
GERNGERON CORP COMcall300,000$52.5Knew

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
RVMDREVOLUTION MEDICINES INC318,782$11.3Mshares
XENEXENON PHARMACEUTICALS INC274,633$9.21Mshares
CGONCG ONCOLOGY INC289,823$7.1Mshares
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INC159,305$7.03Mshares
CYTKCYTOKINETICS INC149,648$6.01Mshares
BLUEPRINT MEDICINES CORPBLUEPRINT MEDICINES CORP61,927$5.48Mshares
EWTXEDGEWISE THERAPEUTICS INC180,255$3.97Mshares
ELVNENLIVEN THERAPEUTICS INC120,430$2.37Mshares
NBIXNEUROCRINE BIOSCIENCES INC21,052$2.33Mshares
ASNDASCENDIS PHARMA A/S14,732$2.3Mshares
SYRESPYRE THERAPEUTICS INC136,139$2.2Mshares
FOLDAMICUS THERAPEUTIC268,919$2.19Mshares
ABUSARBUTUS BIOPHARMA CORP467,882$1.63Mshares
OCULOCULAR THERAPEUTIX INC124,523$913Kshares
DYNDYNE THERAPEUTICS INC84,430$883Kshares
SLNOSOLENO THERAPEUTICS INC11,155$797Kshares
IFRXINFLARX NV725,019$740Kshares
SLDBSOLID BIOSCIENCES INC198,150$733Kshares
SIONSIONNA THERAPEUTICS INC60,000$628Kshares
BCAXBICARA THERAPEUTICS INC47,078$613Kshares
EWTXEDGEWISE THERAPEUTICS INC50,000$238Kput
CVSCVS HEALTH CORP64,100$165Kput
MLYSMINERALYS THERAPEUTICS INC125,000$93.8Kput
ARQTARCUTIS BIOTHERAPEUTICS INC100,000$42.5Kcall
KALVKALVISTA PHARMACEUTICALS INC100,000$32.5Kcall
BBCETFIS SER TR I132,500$16.6Kcall
RYTMRHYTHM PHARMACEUTICALS INC10,000$15.5Kcall
MRKMERCK & CO INC151,700$8.34Kcall
NVONOVO-NORDISK A S151,700$3.79Kcall

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-25-002033 base2025-08-14acceptance time not in the bulk data set